To clarify the role of XOR inhibition in MASLD pathology and its mechanistic connection to metabolic regulation and the JNK/NRF2/HO-1 axis, we inhibited XOR activity in male MASLD rats using febuxostat. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.